PURPOSE: To evaluate complications and results of intravitreal triamcinolone acetonide for treatment of macular edema. DESIGN: Interventional, consecutive, retrospective case series. METHODS: Ninety-three eyes with ma...
Background: There is a need for alternative treatments for the management of exudative age-related macular degeneration (AMD). The purpose of this paper is to determine the feasibility, safety, and clinical effect of ...
Purpose: To report the use of commercially available preservative-free intrav itreal triamcinolone acetonide for the treatment of macular oedema due to retina l vascular diseases. Design: Retrospective interventional ...
Background: Diabetic macular oedema is a frequent cause of visual loss in pati ents with diabetic retinopathy. The purpose of this study was to assess the effi cacy of intravitreal triamcinolone acetonide in reducing ...
PURPOSE: The effectiveness of intravitreal triamcinolone acetonide in the treatment of cystoid macular edema from central retinal vein occlusion (CRVO) was investigated. DESIGN: A noncomparative, prospective, interven...
Aim: To report on visual outcome of patients receiving an intravitreal injecti on of triamcinolone acetonide for treatment of diffuse diabetic macular oedema. Methods: Prospective, comparative, non-randomised clinical...
Purpose: To report on visual outcome of patients receiving an intravitreal inj ection of triamcinolone acetonide as treatment of progressive exudative age-rel ated macular degeneration. Methods: The prospective compar...
BACKGROUNDANDOBJECTIVE: To determine the efficacy of intravitreal triamcinolone acetonide (IVTA) in the early treatment of severe cystoid macular edema (CME) related to acute branch retinal vein occlusion. PATIENTS AN...
Purpose To report pseudohypopyon after intravitreal triamcinolone acetonide in jection for cystoid macular edema. Design Retrospective, noncomparative, consecu tive case series. Methods Records were reviewed of all pa...